Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Bioscript, a full-service pharmaceutical communications company, announced two strategic acquisitions that strengthen and extend its integrated service offering. Fortis Pharma Consulting, a London-based specialist in medical affairs services, brings ...
read more
Carolyn Finkle, Vice President, Global Regulatory Consulting at Catalent Pharma Solutions will present a webinar on “Biosimilars: Current Regulatory Environment and Development and Manufacturing Considerations” for the Pharmaceutical Education and ...
read more
BioSpring announced the development of a pharmaceutical facility dedicated to nucleic acid-based therapeutics in Offenbach. This expansion marks a significant milestone for both the company and Germany’s rapidly growing biotech sector.
read more
BioStem Life Sciences has received it’s ISBT 128 Registration from the ICCBBA.
read more
BioStem Life Sciences announced the buildout of a brand new R&D lab.
read more
Blue Tech Industries has signed a Master Service Agreement with a new customer to manufacture the customer’s amniotic membrane platform for the next two years.
read more
BioStem Technologies Inc., a pre-clinical-stage biotechnology company focused on elements of perinatal tissue for use in regenerative therapies; announced that it has engaged Biologics Consulting, a full-service regulatory and product development ...
read more
Tuesday, October 15, 2013
BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, is pleased to announce that it received a business license from the Chaoyang Commission of Commerce to provide comprehensive sample ...
read more
Thursday, August 15, 2013
BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, announced today that the company has initiated the INTEGRITY Study. The 24-month study will analyze human whole blood samples to ...
read more
Thursday, January 17, 2013
BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, today announced that the company's U.S. biorepository facility has received accreditation from the College of American Pathologists (...
read more
INDIANAPOLIS, March 19, 2012 /PRNewswire/ -- BioStorage Technologies, a global provider of comprehensive sample management solutions, biomaterial storage and cold chain logistics for the bioscience industry, announced today that it will host a live, ...
read more
BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, including storage, cold chain logistics and virtual sample intelligence, will host its European Global Sample Management Benchmarking...
read more
BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, including storage, cold chain logistics and virtual sample intelligence, has announced the appointment of Kristina Robson, Ph.D., as ...
read more
Thursday, October 27, 2016
BioStorage Technologies, Inc. a provider of comprehensive sample lifecycle management for the life sciences industry and subsidiary of Brooks Life Science Systems, has announced the expansion of its sample storage services in the U.S. and ...
read more
Biosynth, a supplier of raw materials to the life science industry, has acquired celares, a developer and manufacturer of conjugate vaccines and bioconjugate drugs, activated PEGs, and polymer-based drug delivery excipients.
read more